UF researcher: gene therapy effective in animal studies of Parkinson's disease

An international team of scientists has reversed some of the effects of Parkinson's disease in rats with a drug-induced form of the progressive movement disorder.

By inserting corrective genes into the brain, researchers were able to trigger the regeneration of a critical bundle of nerve fibers. The new growth was linked to significant -- but not complete -- recovery of the animals' ability to use their paws spontaneously, said Ronald J. Mandel, a University of Florida scientist who was part of the team and a co-author of a recent Journal of Neuroscience article describing the research.

"For a long time, we had known that if the cells that produce the chemical dopamine died, then you would get the effects of Parkinson's disease. Researchers therefore focused on trying to save those cells. But when we were able to do so, we still saw all the signs of the disease," said Mandel, an associate professor in the College of Medicine's neuroscience department who is affiliated with UF's Brain and Genetics institutes.

"What we've shown here is that you can get real functional recovery by instead targeting the treatment to the forebrain. There you can see a regrowth of the fibers or axons that are connected to the dopamine-producing cells. Without that connection, those cells are incapable of supporting normal movement," Mandel said.

Parkinson's disease has been in the news in recent months with the revelation that actor Michael J. Fox has the disorder, which is characterized by rigidity in the arms and legs, tremors and movement difficulties. Some of the symptoms can be alleviated with medications such as levodopa, a drug that converts to dopamine in the brain, but their effectiveness lessens over time. Surgery also can minimize some effects, but there is no cure for the gradually worsening condition, which afflicts an estimated 1.2 million people in the United States and Canada.

The gene therapy experiments were conducted at Lund Uni

Contact: Victoria White
University of Florida

Page: 1 2 3

Related biology news :

1. UF researcher: New low-carb potato to debut in January
2. UF researcher: Animals think in their own way, but unlike humans
3. UF researcher: antioxidants play a role in deadly malnutrition disease
4. Targeted therapy knocks out pediatric brain cancer in mice
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Columbia research to examine gene influence on severity of peridontal disease, therapy response
7. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
8. The search for a kinder, gentler chemotherapy
9. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
10. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
11. Gene changes linked to increased eye pressure may have implications for glaucoma therapy

Post Your Comments:

(Date:8/6/2019)... , ... August 05, 2019 , ... Keck Graduate Institute ... School of Pharmacy and Health Sciences (SPHS). , “Dean Zdanowicz is highly regarded as ... Trustees Chairman Jim Widergren. “He is a great choice to build on the success ...
(Date:8/4/2019)... ... August 02, 2019 , ... Stay on top of ... device and food industries. Access to all webinars is free, so be sure to ... your field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL ...
(Date:8/1/2019)... , ... August 01, 2019 , ... John R. Freeman, ... Fruehauf, MD, PhD, founder and president of BioLabs, which provides premier co-working spaces for ... role to strengthen our ability to forecast and manage growth,” says Fruehauf. “BioLabs has ...
Breaking Biology News(10 mins):
(Date:7/30/2019)... ... July 30, 2019 , ... The summer season has ... company. Not only has the company already hosted many of its signature cooking ... to its guests. , With Lajollacooks4u’s Private Cooking Parties, guests prepare and enjoy ...
(Date:7/19/2019)... ... July 18, 2019 , ... ... their investment to enlarge their current piezo motion facilities in Lederhose, Germany, increasing ... floors for multilayer piezo ceramic assembly production in addition to general office space, ...
(Date:7/17/2019)... , ... July 16, 2019 ... ... long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), ... this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at ...
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the ... National Corn Growers Association (NCGA) announced the winners of the Consider Corn ... product or process using field corn to produce biobased materials. , “Corn is a ...
Breaking Biology Technology:
Cached News: